Sensus Healthcare, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Sensus Healthcare, Inc. (SRTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $8.96 per share for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-05-12
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $8.96.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $4.11.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $4.99.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $6.40, a 66.67% increase from fiscal 2021.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $3.84, a 6.57% decline from fiscal 2020.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $4.11.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $8.58, a 71.94% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2023-03-31 | $8.96 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $6.40 10-K · filed 2023-03-23 | |||
| 2021-12-31 | $3.84 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $3.84 10-Q · filed 2021-11-10 | |||
| 2020-12-31 | $4.11 10-K · filed 2022-03-25 | |||
| 2020-09-30 | $4.11 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | $4.11 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $4.11 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $8.58 10-K · filed 2019-03-15 | |||
| 2017-12-31 | $4.99 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $4.99 10-Q · filed 2017-11-06 | |||
| 2017-06-30 | $4.99 10-Q · filed 2017-08-04 | |||
| 2017-03-31 | $4.99 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $4.42 10-K · filed 2018-02-15 | |||
| 2016-09-30 | $4.42 10-Q · filed 2016-11-07 | |||
| 2016-06-30 | $4.42 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |